These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23872393)
1. Neuroprotective efficacy of subcutaneous insulin-like growth factor-I administration in normotensive and hypertensive rats with an ischemic stroke. De Geyter D; Stoop W; Sarre S; De Keyser J; Kooijman R Neuroscience; 2013 Oct; 250():253-62. PubMed ID: 23872393 [TBL] [Abstract][Full Text] [Related]
2. Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide. De Geyter D; Stoop W; Zgavc T; Sarre S; Michotte Y; De Keyser J; Kooijman R J Neuroinflammation; 2012 May; 9():114. PubMed ID: 22647642 [TBL] [Abstract][Full Text] [Related]
3. Post-stroke treatment with 17β-estradiol exerts neuroprotective effects in both normotensive and hypertensive rats. Stoop W; De Geyter D; Verachtert S; Brouwers S; Verdood P; De Keyser J; Kooijman R Neuroscience; 2017 Apr; 348():335-345. PubMed ID: 28257893 [TBL] [Abstract][Full Text] [Related]
4. Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Fluri F; Grünstein D; Cam E; Ungethuem U; Hatz F; Schäfer J; Samnick S; Israel I; Kleinschnitz C; Orts-Gil G; Moch H; Zeis T; Schaeren-Wiemers N; Seeberger P Exp Neurol; 2015 Mar; 265():142-51. PubMed ID: 25625851 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo. Mackay KB; Loddick SA; Naeve GS; Vana AM; Verge GM; Foster AC J Cereb Blood Flow Metab; 2003 Oct; 23(10):1160-7. PubMed ID: 14526226 [TBL] [Abstract][Full Text] [Related]
6. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by Insulin-like Growth Factor-1 in Rats with Ischemic Stroke is Associated with Microglial Changes and a Reduction in Neuroinflammation. Serhan A; Aerts JL; Boddeke EWGM; Kooijman R Neuroscience; 2020 Feb; 426():101-114. PubMed ID: 31846748 [TBL] [Abstract][Full Text] [Related]
8. Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model. Ninomia T; Wang L; Kumar SR; Kim A; Zlokovic BV J Cereb Blood Flow Metab; 2000 Jun; 20(6):998-1009. PubMed ID: 10894183 [TBL] [Abstract][Full Text] [Related]
9. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats. Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281 [TBL] [Abstract][Full Text] [Related]
10. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial. Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601 [TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. Liu XF; Fawcett JR; Thorne RG; DeFor TA; Frey WH J Neurol Sci; 2001 Jun; 187(1-2):91-7. PubMed ID: 11440750 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Kooijman R; Sarre S; Michotte Y; De Keyser J Stroke; 2009 Apr; 40(4):e83-8. PubMed ID: 19197073 [TBL] [Abstract][Full Text] [Related]
13. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats. Harada N; Shimozawa N; Okajima K Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690 [TBL] [Abstract][Full Text] [Related]
14. Involvement of two distinct signalling pathways in IGF-1-mediated central control of hypotensive effects in normotensive and hypertensive rats. Cheng PW; Kang BH; Lu PJ; Lin SS; Ho WY; Chen HH; Hong LZ; Wu YS; Hsiao M; Tseng CJ Acta Physiol (Oxf); 2014 Sep; 212(1):28-38. PubMed ID: 24995704 [TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. Park MJ; Sohrabji F J Neuroinflammation; 2016 Dec; 13(1):300. PubMed ID: 27905989 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 attenuates apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Tagami M; Ikeda K; Nara Y; Fujino H; Kubota A; Numano F; Yamori Y Lab Invest; 1997 May; 76(5):613-7. PubMed ID: 9166280 [TBL] [Abstract][Full Text] [Related]
17. Antithrombin gamma attenuates macrophage/microglial activation and brain damage after transient focal cerebral ischemia in mice. Nakano T; Nakamura Y; Irie K; Okano S; Morimoto M; Yamashita Y; Kozako T; Hayashi T; Honda SI; Matsuo K; Kamimura H; Ishikura H; Egawa T; Mishima K Life Sci; 2020 Jul; 252():117665. PubMed ID: 32305521 [TBL] [Abstract][Full Text] [Related]
18. A novel caffeoyl triterpene attenuates cerebral ischemic injury with potent anti-inflammatory and hypothermic effects. Ruan Z; Wang HM; Huang XT; Fu Y; Wu J; Ye CY; Li JL; Wu L; Gong Q; Zhao WM; Zhang HY J Neurochem; 2015 Apr; 133(1):93-103. PubMed ID: 25626516 [TBL] [Abstract][Full Text] [Related]
19. IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. O'Donnell SL; Frederick TJ; Krady JK; Vannucci SJ; Wood TL Glia; 2002 Jul; 39(1):85-97. PubMed ID: 12112378 [TBL] [Abstract][Full Text] [Related]